AnaptysBio, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-45.9M | $-47.3M | $1.4M | $15.3M |
| FY2022 | $-73.6M | $-74.0M | $358.0K | $27.4M |
| FY2023 | $-120.8M | $-121.6M | $807.0K | $33.2M |
| FY2024 | $-135.3M | $-135.7M | $358.0K | $7.2M |
| FY2025 | $19.7M | $19.6M | $87.0K | $3.8M |